The GSK3β inhibitor effect was unexpected, since modulating Wnt/β-catenin signaling has had variable effects on liver fibrosis in mouse models (78, 79); in a murine bile duct ligation model, GSK3β inhibitor administration increased the extent of liver fibrosis (80). This evidence concerns the gene GSK3B and Hepatic fibrosis.